Stockscreener 앱 받기
1.02
0.97%
-0.01
시간 외 거래:
1.04
0.02
+1.96%
전일 마감가:
$1.03
열려 있는:
$1.06
하루 거래량:
143.35K
Relative Volume:
0.31
시가총액:
$14.01M
수익:
$11.65M
순이익/손실:
$-36.56M
주가수익비율:
-0.2774
EPS:
-3.677
순현금흐름:
$-30.09M
1주 성능:
-8.11%
1개월 성능:
+12.01%
6개월 성능:
-39.29%
1년 성능:
-65.66%
1일 변동 폭
$1.00
$1.11
1주일 범위
$0.95
$1.14
52주 변동 폭
$0.771
$3.18
Curis Inc Stock (CRIS) Company Profile
명칭
Curis Inc
전화
617-503-6500
주소
128 SPRING STREET, LEXINGTON, MA
Compare CRIS vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRIS
Curis Inc
|
1.02 | 14.15M | 11.65M | -36.56M | -30.09M | -3.677 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Curis Inc Stock (CRIS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2023-11-17 | 개시 | Truist | Buy |
| 2022-04-04 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-10-13 | 개시 | Raymond James | Outperform |
| 2021-03-25 | 개시 | B. Riley Securities | Buy |
| 2020-07-29 | 개시 | Laidlaw | Buy |
| 2020-07-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-10-24 | 개시 | Guggenheim | Buy |
| 2016-03-02 | 개시 | Sun Trust Rbsn Humphrey | Buy |
| 2015-11-09 | 재확인 | ROTH Capital | Buy |
| 2015-08-11 | 개시 | FBR Capital | Outperform |
| 2015-01-22 | 재확인 | Oppenheimer | Outperform |
| 2015-01-21 | 재확인 | ROTH Capital | Buy |
| 2014-05-09 | 재확인 | Oppenheimer | Outperform |
| 2013-10-02 | 개시 | Robert W. Baird | Outperform |
| 2013-09-30 | 개시 | Chardan Capital Markets | Buy |
| 2012-11-14 | 개시 | Stifel Nicolaus | Hold |
| 2012-01-31 | 재확인 | Brean Murray | Buy |
| 2012-01-31 | 재확인 | Summer Street Research | Buy |
| 2011-12-09 | 개시 | Oppenheimer | Outperform |
| 2011-10-06 | 개시 | Summer Street Research | Buy |
| 2011-09-22 | 개시 | MLV Capital | Buy |
| 2011-03-21 | 재확인 | Brean Murray | Buy |
| 2010-02-26 | 재확인 | Roth Capital | Buy |
| 2010-01-07 | 개시 | Roth Capital | Buy |
모두보기
Curis Inc 주식(CRIS)의 최신 뉴스
Head-To-Head Analysis: eXoZymes (NASDAQ:EXOZ) & Curis (NASDAQ:CRIS) - Defense World
Bull Run: Will Curis Inc benefit from AI trendsMarket Risk Summary & Reliable Intraday Trade Plans - baoquankhu1.vn
CRIS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is Curis Inc. a speculative investmentJuly 2025 Rallies & Low Volatility Stock Recommendations - mfd.ru
Aug Chart Watch: Is Curis Inc a potential multi baggerJuly 2025 EndofMonth & Breakout Confirmation Trade Signals - baoquankhu1.vn
Can Curis Inc. stock hit analyst price targetsMarket Activity Recap & Weekly Watchlist for Hot Stocks - mfd.ru
Large share increase and PIPE-driven dilution on ballot at Curis (NASDAQ: CRIS) - Stock Titan
Armistice Capital (CRIS) reports 1.34M shares, 9.99% ownership - Stock Titan
Trading Recap: What are analysts price targets for Curis Inc2025 Buyback Activity & Real-Time Buy Zone Alerts - baoquankhu1.vn
What’s the MACD signal for Curis Inc.July 2025 Retail & Consistent Profit Trading Strategies - mfd.ru
Curis (CRIS) Moves to Offer Over 107 Million Shares of Common St - GuruFocus
Curis Provides Third Quarter 2024 Business Update - GuruFocus
Curis, Inc. (CRIS) stock news today: Live updates - Bitget
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), some shareholders of the biopharmaceutical company Curis Inc plan to resell their ordinary shares in the open market in an irregular and batch-by-batch manner. - Bitget
What are Curis Inc.’s recent SEC filings showing2025 Key Lessons & Real-Time Buy Signal Notifications - mfd.ru
Is Curis Inc. (CUS0) stock positioned for secular growthLayoff News & Low Drawdown Trading Strategies - mfd.ru
How The Narrative Around Curis (CRIS) Is Shifting As Assumptions Change Not The US$14 Target - Yahoo Finance
Curis regains compliance with Nasdaq listing standards, enters monitoring period - Investing.com
Curis Regains Nasdaq Compliance, Remains Under Monitoring Period - TipRanks
Curis (CRIS) targets major share hike to unlock PIPE and new 2026 equity plan - Stock Titan
Curis Advances Clinical Pipeline with Focus on Leukemia Treatments - AD HOC NEWS
Buyout Rumor: Is Curis Inc a potential multi bagger2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Curis (CRIS) to Release Earnings on Wednesday - Defense World
Panic Selling: Is Curis Inc exposed to political riskQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Drivers: Is Curis Inc stock a value trap2025 Technical Patterns & Smart Allocation Stock Tips - baoquankhu1.vn
Is Curis Inc. stock a value trapJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - mfd.ru
Curis Targets BTKi-Exposed CLL With New Emavusertib Combo Trial: What Investors Should Watch - TipRanks
Bond Watch: Is Curis Inc exposed to political risk2025 Macro Impact & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Curis shares jump after lining up up to $80.8m in private placement financing - MSN
Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds - marketscreener.com
Looking At The Narrative For Curis CRIS After Fresh Funding And Fair Value Reset - Yahoo Finance
Curis closes private placement for up to $80.8 million in funding - Investing.com Nigeria
Curis announces closing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Stock Market Recap: Can Curis Inc. stock beat analyst upgradesQuarterly Profit Review & Daily Chart Pattern Signals - Улправда
Is Curis Inc. (CUS0) stock a top dividend aristocrat candidateJuly 2025 Update & Free Risk Controlled Daily Trade Plans - Улправда
Curis prices private placement of $80.8M - MSN
Volume Recap: Can Curis Inc. stock maintain growth trajectoryEntry Point & Consistent Income Trade Recommendations - ulpravda.ru
Curis (NASDAQ: CRIS) sets PIPE financing with warrants and targets 2027 cash runway - Stock Titan
Curis Announces PIPE Financing and Strategic Capital Strengthening - TipRanks
Curis Signs Multiple Material Agreements - TradingView — Track All Markets
Curis announces $80.8 million private placement to fund drug development By Investing.com - Investing.com Nigeria
Curis Inc: Can This Beaten-Down Cancer Stock Still Surprise The Market? - AD HOC NEWS
Aug Breakouts: Can Curis Inc stock maintain growth trajectoryDividend Hike & Daily Profit Maximizing Trade Tips - moha.gov.vn
Curis, Inc. announced that it expects to receive $20.195 million in funding - marketscreener.com
Curis announces $80.8M private placement - TipRanks
Crude Oil Down 2%; ISM Services PMI Surges In December - Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Curis (CRIS) Secures PIPE Deal for Up to $80.8M - GuruFocus
Curis announces pricing of private placement totaling up to $80.8 million in gross proceeds - marketscreener.com
Curis stock soars after securing $80.8 million private placement deal By Investing.com - Investing.com South Africa
Curis stock soars after securing $80.8 million private placement deal - Investing.com India
Curis Inc (CRIS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.69%
0.68%
자본화:
|
볼륨(24시간):